论文部分内容阅读
目的:探讨重症急性胰腺炎的临床治疗方法与效果。方法:选取2013年6月至2015年6月期间来我院接受治疗的106例重症急性胰腺炎患者作为本次研究对象。根据治疗方式的不同将106例患者平均分为研究组(n=53例)与对照组(n=53例)两个小组,对照组的患者采取常规的药物进行治疗,研究组的患者则在其基础上采用中医药疗法进行治疗,观察并对比两组患者的恢复情况以及临床效果。结果:治疗后,研究组患者血淀粉酶、尿淀粉酶、腹痛恢复时间,以及住院时间均少于对照组患者,数据差异显著(P<0.05),具有统计学意义。并且研究组患者(94.34%)的总有效率明显高出对照组患者(83.02%),组间数据差异明显(P<0.05),具有统计学意义。结论:中西结合治疗方式在重症急性胰腺炎患者中的临床疗效显著,安全性高,值得临床推广应用。
Objective: To explore the clinical treatment of severe acute pancreatitis and its effects. METHODS: A total of 106 patients with severe acute pancreatitis treated in our hospital from June 2013 to June 2015 were selected as the study subjects. According to the different treatment methods, 106 patients were equally divided into two groups: study group (n = 53) and control group (n = 53). Patients in the control group were treated with conventional drugs. The study group patients were Based on the use of traditional Chinese medicine therapy for treatment, observation and comparison of two groups of patients recovery and clinical effect. Results: After treatment, the blood amylase, urinary amylase, abdominal pain recovery time and hospital stay in the study group were less than those in the control group, the data were significantly different (P <0.05), with statistical significance. And the total effective rate of the study group (94.34%) was significantly higher than that of the control group (83.02%). There was significant difference between the groups (P <0.05), with statistical significance. Conclusion: The combination of Chinese and western medicine in patients with severe acute pancreatitis has significant clinical efficacy, high safety and worthy of clinical application.